Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.420
+0.070 (2.09%)
At close: Aug 13, 2025, 4:00 PM
3.420
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:42 AM EDT
Relay Therapeutics Employees
Relay Therapeutics had 261 employees as of December 31, 2024. The number of employees decreased by 62 or -19.20% compared to the previous year.
Employees
261
Change (1Y)
-62
Growth (1Y)
-19.20%
Revenue / Employee
$32,011
Profits / Employee
-$1,193,674
Market Cap
589.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 261 | -62 | -19.20% |
| Dec 31, 2023 | 323 | -4 | -1.22% |
| Dec 31, 2022 | 327 | 82 | 33.47% |
| Dec 31, 2021 | 245 | 86 | 54.09% |
| Dec 31, 2020 | 159 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RLAY News
- 6 days ago - Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 12 days ago - Relay Therapeutics: What's Next For H2 2025? - Seeking Alpha
- 13 days ago - Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 - GlobeNewsWire
- 2 months ago - Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors - GlobeNewsWire
- 2 months ago - Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 - GlobeNewsWire
- 2 months ago - Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June - GlobeNewsWire
- 3 months ago - Relay Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire